EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Vagal Nerve Stimulation as Therapy for Drug-Resistant Epilepsy: A Tertiary Hospital Experience of Outcomes and Efficacy in King Abdullah Medical City

Bassam G Sef, Abeer S AlBalawi, Ahmed M AlHajji, Muhammed M Irfan, Hanadi M Abu AlEla

Neurosciences · 27.03.2026 · 31 (1) · 85-88

DOI: 10.17712/1658-3183.1012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurosciences, online erschienen am 27.03.2026. Verfasst von Bassam G Sef und 4 weiteren Autor:innen. Beteiligte Einrichtung: Associate Consultant Neurology, King Abdullah Medical City, Makkah, Kingdom of Saudi Arabia. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Vagus Nerve Stimulation. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To determine the efficacy and safety of vagus nerve stimulation (VNS) for reducing the frequency of seizures and complications in drug-resistant epilepsy.

Methods

This was a retrospective case series study conducted in King Abdullah Medical City from January 2015 to December 2021 hospital record. All patients undergoing VNS were enrolled according to inclusion and exclusion criteria. Patients were followed up for 12 months, and the seizure frequency and number of epileptic drugs used were evaluated. A paired sample t-test was applied to compare the outcome variables considering p-value < 0.05 as significant.

Results

Among 9 enrolled patients, four were females, and five were males. The mean age of the patients was 23.9 ± 10.8 years. The average number\\enlargethispage12pt of drugs used before VNS was 3, while it was 2 after VNS. However, a statistically significant (p = 0.08) reduction was not achieved. The mean seizure frequency before and after VNS was 14.4 ± 4.0 and 2.2 ± 3.2 at the 12-month follow-up visit (p < 0.05). The seizure frequency was statistically significantly reduced since the p-value was less than 0.05. No significant complications or death were observed.

Conclusion

The VNS is a safe and effective adjuvant therapy for reducing the frequency of seizures in patients with drug-resistant epilepsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistant EpilepsyVagus Nerve StimulationAdolescentAdultFemaleHumansMaleYoung AdultAnticonvulsantsRetrospective StudiesTertiary Care CentersTreatment Outcome

Stichwörter der Autor:innen

Drug resistant epilepsyIntractable epilepsyRefractory epilepsyVNSVagal nerve stimulation

Substanzen

Anticonvulsants

Autor:innen und Institutionen

  • Associate Consultant Neurology, King Abdullah Medical City, Makkah, Kingdom of Saudi Arabia.
  • Neurology senior registrar, King Fahad Specialist Hospital, Tabuk.
  • Senior neurology resident, King Abdullah Medical City, Makkah, Kingdom of Saudi Arabia.
  • Assistant Consultant Neurology, King Abdullah Medical City, Makkah, Kingdom of Saudi Arabia.
  • Neurology Consultant, Epileptologist, King Abdullah Medical City, Makkah, Kingdom of Saudi Arabia.

Zitieren

APA

Sef, B. G., AlBalawi, A. S., AlHajji, A. M., Irfan, M. M., & Abu AlEla, H. M. (2026). Vagal Nerve Stimulation as Therapy for Drug-Resistant Epilepsy: A Tertiary Hospital Experience of Outcomes and Efficacy in King Abdullah Medical City. Neurosciences, 31(1), 85-88. https://doi.org/10.17712/1658-3183.1012

Vancouver

Sef BG, AlBalawi AS, AlHajji AM, Irfan MM, Abu AlEla HM. Vagal Nerve Stimulation as Therapy for Drug-Resistant Epilepsy: A Tertiary Hospital Experience of Outcomes and Efficacy in King Abdullah Medical City. Neurosciences. 2026;31(1):85-88. doi:10.17712/1658-3183.1012

BibTeX
@article{Sef2026,
  author = {Sef, Bassam G and AlBalawi, Abeer S and AlHajji, Ahmed M and Irfan, Muhammed M and Abu AlEla, Hanadi M},
  title = {Vagal Nerve Stimulation as Therapy for Drug-Resistant Epilepsy: A Tertiary Hospital Experience of Outcomes and Efficacy in King Abdullah Medical City},
  journal = {Neurosciences},
  year = {2026},
  volume = {31},
  number = {1},
  pages = {85--88},
  doi = {10.17712/1658-3183.1012}
}
Kostenlos starten →